Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Inogen, Inc. INGN recently announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

As a nurse, I’ve seen how the virus can cause serious health complications. Check out the following items to keep on hand to ...

Part of what makes medical emergencies so scary is that, by nature, they can happen completely unexpectedly.

If you’ve made a habit of staring at a computer all day, you might be familiar with the dreaded feeling of eye strain — which ...

Companies are set to increase prices of daily essentials and electronics due to rising input costs and rupee depreciation. FMCG firms like Hindustan Unilever and Godrej plan further price hikes ...